Early Life
Li Li's early career began outside the pharmaceutical industry. He worked at the Chengdu Meat Processing Factory.
Rise to Success
Li's first role in the pharmaceutical industry was at heparin producer Chongqing Tongda. In 1998, Li founded Shenzhen Hepalink Pharmaceutical Group Co., Ltd.. Under his leadership, Hepalink has become a global company with over 2,000 employees, business in more than 40 countries, and 8 manufacturing sites. Li invented advanced heparin processing technologies that helped make China a world leader in high-yield heparin purification.
Key Business Strategies
Li's key business strategy involved developing and implementing innovative heparin processing technologies. This approach enabled Hepalink to create China's first generic enoxaparin, which was approved in the EU and became a market leader in Europe. Hepalink has since expanded its business model to include the heparin industrial chain, CDMO services for large-molecule biologics, and the research, development, and commercialization of innovative drugs.
Philanthropy
Information on Li Li's specific philanthropic endeavors could not be found. However, based on available information about other individuals named Li, there are several related philanthropic organizations, such as the Li Foundation, but there is no direct connection between the company chairman and these organizations.